News Releases

<< Back
Prestige Brands Holdings, Inc. to Release Fiscal 2011 Second Quarter
Earnings on November 4th

IRVINGTON, N.Y., Oct 11, 2010 (BUSINESS WIRE) --

Prestige Brands Holdings, Inc. (NYSE: PBH) today announced that it will issue its fiscal 2011 second quarter earnings on Thursday, November 4, 2010 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m.

To access the conference call, listeners calling from within North America may dial 866-383-8119 about 10 minutes prior to the start of the call. Those wishing to access the call from outside North America should dial 617-597-5344. The conference pass code is "prestige". The Company will provide a live internet web cast as well as an archived replay, which can be accessed from the Investor Relations page of http://prestigebrandsinc.com.

Telephonic replays will be available for two weeks following completion of the live call and can be accessed at 888-286-8010 within North America, and at 617-801-6888 from outside North America. The pass code is 49548893.

Prestige Brands markets and distributes brand name over-the-counter healthcare and household products throughout the United States, Canada and certain international markets. Key brands include Compound W(R) wart treatments, Chloraseptic(R) sore throat relief and allergy treatment products, New-Skin(R) liquid bandage, Clear Eyes(R) and Murine(R) eye care products, Little Remedies(R) pediatric over-the-counter healthcare products, The Doctor's(R) NightGuard(R), Comet(R) and Spic and Span(R) household cleaners, and other well-known brands.

SOURCE: Prestige Brands Holdings, Inc.

Prestige Brands Holdings, Inc.
Dean Siegal, 914-524-6819

Primary IR Contact

Irinquiries@prestigebrands.com
Prestige Consumer Healthcare Inc.
660 White Plains Road – Ste 250
Tarrytown, NY 10591
Telephone: 914-524-6819

Transfer Agent

AST
6201 15th Avenue
Brooklyn, NY 11219
Telephone: (800) 937-5449
help@astfinancial.com
https://www.astfinancial.com

Subscribe

Stay up to date with investor news, stock information and SEC filings.
Subscribe »